Browse > Article
http://dx.doi.org/10.5487/TR.2017.33.1.063

Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor  

Park, Jisoo (Department of Pharmacology and Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Research Institute for Medical Sciences, College of Medicine, Chungnam National University)
Lee, Hyunji (Department of Pharmacology and Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Research Institute for Medical Sciences, College of Medicine, Chungnam National University)
Tran, Quangdon (Department of Pharmacology and Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Research Institute for Medical Sciences, College of Medicine, Chungnam National University)
Mun, Kisun (Department of Pharmacology and Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Research Institute for Medical Sciences, College of Medicine, Chungnam National University)
Kim, Dohoon (Department of Pharmacology and Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Research Institute for Medical Sciences, College of Medicine, Chungnam National University)
Hong, Youngeun (Department of Pharmacology and Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Research Institute for Medical Sciences, College of Medicine, Chungnam National University)
Kwon, So Hee (College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Yonsei University)
Brazil, Derek (Centre for Experimental Medicine, Queen's University Belfast)
Park, Jongsun (Department of Pharmacology and Medical Science, Metabolic Syndrome and Cell Signaling Laboratory, Research Institute for Medical Sciences, College of Medicine, Chungnam National University)
Kim, Seon-Hwan (Department of Neurosurgery, Institute for Cancer Research, College of Medicine, Chungnam National University)
Publication Information
Toxicological Research / v.33, no.1, 2017 , pp. 63-69 More about this Journal
Abstract
Transmembrane protein 39A (TMEM39A) belongs to the TMEM39 family. TMEM39A gene is a susceptibility locus for multiple sclerosis. In addition, TMEM39A seems to be implicated in systemic lupus erythematosus. However, any possible involvement of TMEM39A in cancer remains largely unknown. In the present report, we provide evidence that TMEM39A may play a role in brain tumors. Western blotting using an anti-TMEM39A antibody indicated that TMEM39A was overexpressed in glioblastoma cell lines, including U87-MG and U251-MG. Deep-sequencing transcriptomic profiling of U87-MG and U251-MG cells revealed that TMEM39A transcripts were upregulated in such cells compared with those of the cerebral cortex. Confocal microscopic analysis of U251-MG cells stained with anti-TMEM39A antibody showed that TMEM39A was located in dot-like structures lying close to the nucleus. TMEM39A probably located to mitochondria or to endosomes. Immunohistochemical analysis of glioma tissue specimens indicated that TMEM39A was markedly upregulated in such samples. Bioinformatic analysis of the Rembrandt knowledge base also supported upregulation of TMEM39A mRNA levels in glioma patients. Together, the results afford strong evidence that TMEM39A is upregulated in glioma cell lines and glioma tissue specimens. Therefore, TMEM39A may serve as a novel diagnostic marker of, and a therapeutic target for, gliomas and other cancers.
Keywords
TMEM39a; Multiple sclerosis; Systemic lupus erythematosus; Glioma;
Citations & Related Records
Times Cited By KSCI : 4  (Citation Analysis)
연도 인용수 순위
1 Friedmann-Morvinski, D., Bushong, E.A., Ke, E., Soda, Y., Marumoto, T., Singer, O., Ellisman, M.H. and Verma, I.M. (2012) Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice. Science, 338, 1080-1084.   DOI
2 Arif, S.H., Pandith, A.A., Bhat, A.R., Ramzan, A.U., Malik, N.K., Chibber, S.S., Wani, A.A., Tabasum, R. and Kirmani, A. (2015) EGFR and PTEN gene mutation status in glioblastoma patients and their prognostic impact on patient's survival. J. Carcinog. Mutagen., 6, 218.
3 Virk, S.M., Gibson, R.M., Quinones-Mateu, M.E. and Barnholtz-Sloan, J.S. (2015) Identification of variants in primary and recurrent glioblastoma using a cancer-specific gene panel and whole exome sequencing. PLoS ONE, 10, e0124178.   DOI
4 Wesseling, P., Ruiter, D.J. and Burger, P.C. (1997) Angiogenesis in brain tumors; pathobiological and clinical aspects. J Neurooncol., 32, 253-265.   DOI
5 Jain, R.K., di Tomaso, E., Duda, D.G., Loeffler, J.S., Sorensen, A.G. and Batchelor, T.T. (2007) Angiogenesis in brain tumours. Nat. Rev. Neurosci., 8, 610-622.
6 Das, S. and Marsden, P.A. (2013) Angiogenesis in glioblastoma. N. Engl. J. Med., 369, 1561-1563.   DOI
7 Carmeliet, P. and Jain, R.K. (2011) Molecular mechanisms and clinical applications of angiogenesis. Nature, 473, 298-307.   DOI
8 Norden, A.D., Drappatz, J. and Wen, P.Y. (2008) Novel antiangiogenic therapies for malignant gliomas. Lancet Neurol., 7, 1152-1160.   DOI
9 Chinot, O.L., Wick, W., Mason, W., Henriksson, R., Saran, F., Nishikawa, R., Carpentier, A.F., Hoang-Xuan, K., Kavan, P., Cernea, D., Brandes, A.A., Hilton, M., Abrey, L. and Cloughesy, T. (2014) Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma. N. Engl. J. Med., 370, 709-722.   DOI
10 Chinot, O.L., Macdonald, D.R., Abrey, L.E., Zahlmann, G., Kerloeguen, Y. and Cloughesy, T.F. (2013) Response assessment criteria for glioblastoma: practical adaptation and implementation in clinical trials of antiangiogenic therapy. Curr. Neurol. Neurosci. Rep., 13, 347.   DOI
11 International Multiple Sclerosis Genetics Consortium (IMSGC) (2010) Comprehensive follow-up of the first genome-wide association study of multiple sclerosis identifies KIF21B and TMEM39A as susceptibility loci. Hum. Mol. Genet., 19, 953-962.   DOI
12 Gilbert, M.R., Dignam, J.J., Armstrong, T.S., Wefel, J.S., Blumenthal, D.T., Vogelbaum, M.A., Colman, H., Chakravarti, A., Pugh, S., Won, M., Jeraj, R., Brown, P.D., Jaeckle, K.A., Schiff, D., Stieber, V.W., Brachman, D.G., Werner-Wasik, M., Tremont-Lukats, I.W., Sulman, E.P., Aldape, K.D., Curran, W.J., Jr. and Mehta, M.P. (2014) A randomized trial of bevacizumab for newly diagnosed glioblastoma. N. Engl. J. Med., 370, 699-708.   DOI
13 Hao, Y., Colak, R., Teyra, J., orbi-Verge, C., Ignatchenko, A., Hahne, H., Wilhelm, M., Kuster, B., Braun, P., Kaida, D., Kislinger, T. and Kim, P.M. (2015) Semi-supervised learning predicts approximately one third of the alternative splicing isoforms as functional proteins. Cell Rep., 12, 183-189.   DOI
14 Moon, C.P. and Fleming, K.G. (2011) Side-chain hydrophobicity scale derived from transmembrane protein folding into lipid bilayers. Proc. Natl. Acad. Sci. U.S.A., 108, 10174-10177.   DOI
15 Li, Y., Park, J., Piao, L., Kong, G., Kim, Y., Park, K.A., Zhang, T., Hong, J., Hur, G.M., Seok, J.H., Choi, S.W., Yoo, B.C., Hemmings, B.A., Brazil, D.P., Kim, S.H. and Park, J. (2013) PKB-mediated PHF20 phosphorylation on Ser291 is required for p53 function in DNA damage. Cell. Signal., 25, 74-84.   DOI
16 Varade, J., Comabella, M., Ortiz, M.A., Arroyo, R., Fernandez, O., Pinto-Medel, M.J., Fedetz, M., Izquierdo, G., Lucas, M., Gomez, C.L., Rabasa, A.C., Alcina, A., Matesanz, F., Alloza, I., Antiguedad, A., Garcia-Barcina, M., Otaegui, D., Olascoaga, J., Saiz, A., Blanco, Y., Montalbán, X., Vandenbroeck, K. and Urcelay, E. (2012) Replication study of 10 genes showing evidence for association with multiple sclerosis: validation of TMEM39A, IL12B and CBLB [correction of CLBL] genes. Mult. Scler., 18, 959-965.   DOI
17 You, Y., Zhai, Z.F., Chen, F.R., Chen, W. and Hao, F: (2015) Autoimmune risk loci of IL12RB2, IKZF1, XKR6, TMEM39A and CSK in Chinese patients with systemic lupus erythematosus. Tissue Antigens, 85, 200-203.   DOI
18 Sheng, Y.J., Xu, J.H., Wu, Y.G., Zuo, X.B., Gao, J.P., Lin, Y., Zhu, Z.W., Wen, L.L., Yang, C., Liu, L., Cheng, Y.Y., Chang, Y., Yang, L.L., Zhou, F.S., Tang, X.F., Zheng, X.D., Yin, X.Y., Tang, H.Y., Sun, L.D., Cui, Y., Yang, S. and Zhang, X.J. (2015) Association analyses confirm five susceptibility loci for systemic lupus erythematosus in the Han Chinese population. Arthritis Res. Ther., 17, 85.   DOI
19 Lessard, C.J., Adrianto, I., Ice, J.A., Wiley, G.B., Kelly, J.A., Glenn, S.B., Adler, A.J., Li, H., Rasmussen, A., Williams, A.H., Ziegler, J., Comeau, M.E., Marion, M., Wakeland, B.E., Liang, C., Ramos, P.S., Grundahl, K.M., Gallant, C.J., Alarcón-Riquelme, M.E., Alarcon, G.S., Anaya, J.M., Bae, S.C., Boackle, S.A., Brown, E.E., Chang, D.M., Cho, S.K., Criswell, L.A., Edberg, J.C., Freedman, B.I., Gilkeson, G.S., Jacob, C.O., James, J.A., Kamen, D.L., Kimberly, R.P., Kim, J.H., Martin, J., Merrill, J.T., Niewold, T.B., Park, S.Y., Petri, M.A., Pons-Estel, B.A., Ramsey-Goldman, R., Reveille, J.D., Scofield, R.H., Song, Y.W., Stevens, A.M., Tsao, B.P., Vila, L.M., Vyse, T.J., Yu, C.Y., Guthridge, J.M., Kaufman, K.M., Harley, J.B., Wakeland, E.K., Langefeld, C.D., Gaffney, P.M., Montgomery, C.G. and Moser, K.L. (2012) Identification of IRF8, TMEM39A, and IKZF3-ZPBP2 as susceptibility loci for systemic lupus erythematosus in a large-scale multiracial replication study. Am. J. Hum. Genet., 90, 648-660.   DOI
20 Kim, A.Y., Kwak, J.H., Je, N.K., Lee, Y.H. and Jung, Y.S. (2015) Epithelial-mesenchymal transition is associated with acquired resistance to 5-fluorocuracil in HT-29 colon cancer cells. Toxicol. Res., 31, 151-156.   DOI
21 Zhang, J., Ma, Y., Qiu, M., Yang, L., Bu, Y. and Tang, X. (2014) Correlation between TMEM39A gene polymorphism and systemic lupus erythematosus in Chinese Han patients. Nan Fang Yi Ke Da Xue Xue Bao, 34, 556-559.
22 Kim, I.S., Yang, S.Y., Han, J.H., Jung, S.H., Park, H.S. and Myung, C.S. (2015) Differential gene expression in GPR40- overexpressing pancreatic ${\beta}$-cells treated with linoleic acid. Korean J. Physiol. Pharmacol., 19, 141-149.   DOI
23 Bioinformatics, U.G. (2015) Human Genome Sequencing Consortium. Available from: http://genome.ucsc.edu/.
24 Kim, D. and Salzberg, S. (2015) TopHat 2.1.0 release [cited 2015 Jun 29]. Available from: https://ccb.jhu.edu/software/tophat/index.shtml/.
25 Na, C.H., Hong, J.H., Kim, W.S., Shanta, S.R., Bang, J.Y., Park, D., Kim, H.K. and Kim, K.P. (2015) Identification of protein markers specific for papillary renal cell carcinoma using imaging mass spectrometry. Mol. Cells, 38, 624-629.   DOI
26 Cheon, J.M., Kim, D.I. and Kim, K.S. (2015) Insulin sensitivity improvement of fermented Korean Red Ginseng (Panax ginseng) mediated by insulin resistance hallmarks in old-aged ob/ob mice. J. Ginseng Res., 39, 331-337.   DOI
27 Goodman, S.R. (2008) Medical cell biology in Medical Cell Biology (Goodman, S.R. Ed.). Academic Press, p. 37.